% Expired Patents = 87.5

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 3

Loading Chart...

8 inventors (with patents filed for the assignee):

Sandro Boland (8 out of 10 patents)

Dirk Leysen (8 out of 10 patents)

Olivier Defert (7 out of 9 patents)

4. Arnaud Pierre Jean Bourin (5 out of 5 patents)

5. Jo Alen (4 out of 4 patents)

6. Petra Blom (2 out of 6 patents)

7. Nadzeya Kaval (2 out of 2 patents)

8. Oliver Defert (1 out of 1 patent)

9. Arnaud Bourin (2 patents)

8 patents: Sort by Forward Citations

1. 9394286 - Rock inhibitors (2016-07-19),

2. 9174939 - Soft rock inhibitors (2015-11-03),

3. 9126933 - Soft PDE4 inhibitors (2015-09-08),

4. 9079858 - Rock kinase inhibitors (2015-07-14),

5. 9073905 - Rock inhibitors (2015-07-07),

6. 9067889 - Biphenylcarboxamides as ROCK kinase inhibitors (2015-06-30),

7. 8912209 - Rock inhibitors (2014-12-16),

8. 8815873 - Heterocyclic amides as rock inhibitors (2014-08-26),

Amakem NV is a biopharmaceutical company that focuses on the development of novel therapeutics for the treatment of glaucoma. Their lead product candidate, AMA0076, is a kinase inhibitor designed to lower intraocular pressure in patients with glaucoma. The company is dedicated to advancing innovative solutions for ophthalmic diseases through rigorous research and development.

Profile summary based on public USPTO records.